Empire Genomics Licenses First Known DNA Biomarker for Multiple Myeloma

News   Nov 29, 2012

 
Empire Genomics Licenses First Known DNA Biomarker for Multiple Myeloma
 
 
 

RELATED ARTICLES

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

Possible Biomarker to Identify Who Would Benefit from Immunotherapy

News

While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.

READ MORE

Longevity Protein Could Help Treat Diabetes

News

beta-Klotho, a protein that regulates longevity, could have therapeutic potential for diabetes and obesity.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE